The Biotech Growth Trust PLC (LON:BIOG) Insider Hamish Baillie Buys 3,000 Shares

The Biotech Growth Trust PLC (LON:BIOG) insider Hamish Baillie purchased 3,000 shares of the firm’s stock in a transaction on Wednesday, November 27th. The shares were purchased at an average price of GBX 931 ($11.80) per share, for a total transaction of £27,930 ($35,408.22).

The Biotech Growth Trust Trading Up 0.7 %

Shares of BIOG stock traded up GBX 6.40 ($0.08) on Thursday, hitting GBX 956.40 ($12.12). The stock had a trading volume of 48,433 shares, compared to its average volume of 68,725. The firm has a market capitalization of £307.29 million, a P/E ratio of 459.90 and a beta of 0.50. The company has a debt-to-equity ratio of 13.03, a current ratio of 0.33 and a quick ratio of 0.00. The company’s 50 day moving average price is GBX 1,006.62 and its 200-day moving average price is GBX 1,000.45. The Biotech Growth Trust PLC has a 1 year low of GBX 736.30 ($9.33) and a 1 year high of GBX 1,068.36 ($13.54).

The Biotech Growth Trust Company Profile

The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the biotechnology sector. The fund invests in stocks of companies across all market capitalizations.